A graphic design with a dark blue left section containing a blue pill icon, a red middle section with white text that says 'ABSTRACT SUBMISSIONS,' and a right orange section with a beige plus icon.

ABSTRACT & SPARK TANK SUBMISSIONS ARE NOW CLOSED

The committee are working hard to review abstracts as quickly as possible. Submitters will recieve an email as soon as possible advising the outcome of your submission.

Frequently Asked Questions

  • Yes, submitters can edit their submission (including Title, Content, Authors or Presenting Author) after they have submitted it, up until the submission deadline.

    Submitters can do this through their online registration dashboard. Click on the Abstracts tab and then on the “View submission" button to edit the abstract.

  • Abstract submission deadline has been extended to 23:59 AWST, 19 July 2026

    Late submissions will not be accepted.

  • Abstracts will be reviewed and scored on a rolling basis.

    Notification of program decisions will come from the Congress Team via email on a rolling basis.

    Decisions will also appeared on the submitter’s own ‘dashboard’.

    Applicants requesting travel support are strongly encouraged to submit early to allow sufficient time for award notifications and visa application processing, if selected.

  • Yes. A late-breaking abstract window for research completed after the initial deadline will be announced in August.

  • Abstracts must:

    • Present original research

    • Not have been previously published in full at the time of submission

    • Be submitted in English

    • Be 300 words or fewer

    • Use a structured format oulined above for each General Abstracts & Clinical Case Abstract submissions

    • Be submitted via the online abstract portal

  • Accepted abstracts may be assigned to:

    • Oral presentation (plenary session)

    • Oral presentation (symposium session)

    • Poster presentation

  • Yes. During submission you can indicate the format you’d like to be considered for.

  • The Scientific Committee, based on peer-review scoring and overall programme balance.

  • Yes. Each author must disclose any relevant financial relationships with providers of commercial products/services discussed, or that supported the CME activity via an educational grant.

  • You must clearly state if a product is off-label for the use described or is investigational.

  • Yes. All accepted abstracts will be published in a special issue of Global Heart and will remain embargoed until publication.